Τετάρτη, 21 Αυγούστου 2019

Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance

Stacie K. Totsch, Charles Schlappi, Kyung-Don Kang, Andrew S. Ishizuka, Geoffrey M. Lynn et al. 
Oncogene 2019 38 :6159 - 6171; July 09, 2019; 10.1038/s41388-019-0870-y

Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players

Xiaotian Yuan, Catharina Larsson & Dawei Xu 
Oncogene 2019 38 :6172 - 6183; July 08, 2019; 10.1038/s41388-019-0872-9

ARTICLE

Mutant p53 improves cancer cells’ resistance to endoplasmic reticulum stress by sustaining activation of the UPR regulator ATF6

Daria Sicari, Marco Fantuz, Arianna Bellazzo, Elena Valentino, Mattia Apollonio et al. 
Oncogene 2019 38 :6184 - 6195; July 16, 2019; 10.1038/s41388-019-0878-3

SOX7 regulates MAPK/ERK-BIM mediated apoptosis in cancer cells

Qiao-Yang Sun, Ling-Wen Ding, Kara Johnson, Siqin Zhou, Jeffrey W. Tyner et al. 
Oncogene 2019 38 :6196 - 6210; July 22, 2019; 10.1038/s41388-019-0865-8

MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma

Nathanael H. Green, Daniel L. Galvan, Shawn S. Badal, Benny H. Chang, Valerie S. LeBleu et al. 
Oncogene 2019 38 :6211 - 6225; July 09, 2019; 10.1038/s41388-019-0869-4

Epigenetic reprogramming of primary pancreatic cancer cells counteracts their in vivo tumourigenicity

Reyhaneh Khoshchehreh, Mehdi Totonchi, Juan Carlos Ramirez, Raul Torres, Hossein Baharvand et al. 
Oncogene 2019 38 :6226 - 6239; July 15, 2019; 10.1038/s41388-019-0871-x

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου